These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 23977378

  • 1. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
    Vardi-Oknin D, Golan M, Mabjeesh NJ.
    PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
    [Abstract] [Full Text] [Related]

  • 2. SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.
    Golan M, Mabjeesh NJ.
    Cell Cycle; 2013 Jul 15; 12(14):2297-308. PubMed ID: 24067372
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-α7 to drive hypoxia-inducible factor (HIF)-1α nuclear translocation.
    Tazat K, Schindler S, Depping R, Mabjeesh NJ.
    Cytoskeleton (Hoboken); 2019 Jan 15; 76(1):123-130. PubMed ID: 29742803
    [Abstract] [Full Text] [Related]

  • 6. A Septin Cytoskeleton-Targeting Small Molecule, Forchlorfenuron, Inhibits Epithelial Migration via Septin-Independent Perturbation of Cellular Signaling.
    Sun L, Cao X, Lechuga S, Feygin A, Naydenov NG, Ivanov AI.
    Cells; 2019 Dec 29; 9(1):. PubMed ID: 31905721
    [Abstract] [Full Text] [Related]

  • 7. Off-target effects of the septin drug forchlorfenuron on nonplant eukaryotes.
    Heasley LR, Garcia G, McMurray MA.
    Eukaryot Cell; 2014 Nov 29; 13(11):1411-20. PubMed ID: 25217460
    [Abstract] [Full Text] [Related]

  • 8. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation.
    Amir S, Wang R, Simons JW, Mabjeesh NJ.
    J Biol Chem; 2009 Apr 24; 284(17):11142-51. PubMed ID: 19251694
    [Abstract] [Full Text] [Related]

  • 9. [Mechanism of nuclear translocation of hypoxia-inducible factor-1α in influenza A (H1N1) virus infected-alveolar epithelial cells].
    Meng X, Guo X, Zhu Y, Xie H, Wang R.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan 24; 32(1):8-13. PubMed ID: 32148224
    [Abstract] [Full Text] [Related]

  • 10. Forchlorfenuron alters mammalian septin assembly, organization, and dynamics.
    Hu Q, Nelson WJ, Spiliotis ET.
    J Biol Chem; 2008 Oct 24; 283(43):29563-71. PubMed ID: 18713753
    [Abstract] [Full Text] [Related]

  • 11. Oltipraz and dithiolethione congeners inhibit hypoxia-inducible factor-1alpha activity through p70 ribosomal S6 kinase-1 inhibition and H2O2-scavenging effect.
    Lee WH, Kim YW, Choi JH, Brooks SC, Lee MO, Kim SG.
    Mol Cancer Ther; 2009 Oct 24; 8(10):2791-802. PubMed ID: 19789218
    [Abstract] [Full Text] [Related]

  • 12. SEPT9_i1 and Septin Dynamics in Oncogenesis and Cancer Treatment.
    Jędrzejczak P, Saramowicz K, Kuś J, Barczuk J, Rozpędek-Kamińska W, Siwecka N, Galita G, Wiese W, Majsterek I.
    Biomolecules; 2024 Sep 22; 14(9):. PubMed ID: 39334960
    [Abstract] [Full Text] [Related]

  • 13. Development of Potent Forchlorfenuron Analogs and Their Cytotoxic Effect in Cancer Cell Lines.
    Kim KK, Singh RK, Khazan N, Kodza A, Singh NA, Jones A, Sivagnanalingam U, Towner M, Itamochi H, Turner R, Moore RG.
    Sci Rep; 2020 Feb 24; 10(1):3241. PubMed ID: 32094384
    [Abstract] [Full Text] [Related]

  • 14. Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.
    Marcus EA, Tokhtaeva E, Turdikulova S, Capri J, Whitelegge JP, Scott DR, Sachs G, Berditchevski F, Vagin O.
    Biochem J; 2016 Jun 15; 473(12):1703-18. PubMed ID: 27048593
    [Abstract] [Full Text] [Related]

  • 15. Cellular requirements for the small molecule forchlorfenuron to stabilize the septin cytoskeleton.
    DeMay BS, Meseroll RA, Occhipinti P, Gladfelter AS.
    Cytoskeleton (Hoboken); 2010 Jun 15; 67(6):383-99. PubMed ID: 20517926
    [Abstract] [Full Text] [Related]

  • 16. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
    Zeng Y, Cao Y, Liu L, Zhao J, Zhang T, Xiao L, Jia M, Tian Q, Yu H, Chen S, Cai Y.
    Cell Death Dis; 2019 Sep 26; 10(10):720. PubMed ID: 31558699
    [Abstract] [Full Text] [Related]

  • 17. MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis.
    Amir S, Wang R, Matzkin H, Simons JW, Mabjeesh NJ.
    Cancer Res; 2006 Jan 15; 66(2):856-66. PubMed ID: 16424018
    [Abstract] [Full Text] [Related]

  • 18. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM, Padgaonkar AA, Jalota-Badhwar A, Rao SV, Joshi KS.
    Prostate Cancer Prostatic Dis; 2012 Mar 15; 15(1):15-27. PubMed ID: 22083267
    [Abstract] [Full Text] [Related]

  • 19. In silico docking of forchlorfenuron (FCF) to septins suggests that FCF interferes with GTP binding.
    Angelis D, Karasmanis EP, Bai X, Spiliotis ET.
    PLoS One; 2014 Mar 15; 9(5):e96390. PubMed ID: 24787956
    [Abstract] [Full Text] [Related]

  • 20. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
    Takata K, Morishige K, Takahashi T, Hashimoto K, Tsutsumi S, Yin L, Ohta T, Kawagoe J, Takahashi K, Kurachi H.
    Mol Cancer Ther; 2008 Jun 15; 7(6):1551-61. PubMed ID: 18566226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.